scholarly article | Q13442814 |
P2093 | author name string | F A McAlister | |
K K Teo | |||
A M Buchan | |||
A Shuaib | |||
W A Ghali | |||
L B Mitchell | |||
R T Tsuyuki | |||
T J Bungard | |||
A J Cave | |||
P G Hamilton | |||
P2860 | cites work | Why do patients with atrial fibrillation not receive warfarin? | Q33815598 |
Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project | Q68697007 | ||
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials | Q72030226 | ||
Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly | Q72440457 | ||
The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators | Q73414845 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | (RS)-warfarin | Q407431 |
Atrial Fibrillation | Q815819 | ||
P304 | page(s) | 301-302 | |
P577 | publication date | 2001-08-01 | |
P1433 | published in | Canadian Medical Association Journal | Q5030320 |
P1476 | title | Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation | |
P478 | volume | 165 |
Q24803243 | A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643] |
Q37203662 | Capsule commentary on Efird et al., identifying the risks of anticoagulation in patients with substance abuse |
Q35636477 | Do population studies confirm the benefit of oral anticoagulation in atrial fibrillation demonstrated in clinical trials? |
Q39631749 | Evaluating the Usability and Perceived Impact of an Electronic Medical Record Toolkit for Atrial Fibrillation Management in Primary Care: A Mixed-Methods Study Incorporating Human Factors Design |
Q37453028 | Explicit risk in acute coronary syndrome management |
Q35806598 | Impact of Rural Residence on Warfarin Use and Clinical Events in Patients with Non-Valvular Atrial Fibrillation: A Canadian Population Based Study. |
Q34087971 | Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians. |
Q34100740 | Improving outpatient warfarin use for hospitalized patients with atrial fibrillation |
Q30830699 | Improving stroke prevention therapy for patients with atrial fibrillation in primary care: protocol for a pragmatic, cluster-randomized trial. |
Q35790677 | Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial |
Q37149490 | International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation |
Q28190407 | New treatment options for stroke prevention in atrial fibrillation |
Q35906247 | Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study |
Q92378495 | Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry |
Q35827933 | The decision to anticoagulate: assessing whether benefits outweigh the risks for patients with atrial fibrillation |
Q36951700 | Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age. |
Q36472606 | What are the barriers to warfarin use in atrial fibrillation?: Development of a questionnaire. |
Search more.